Andrew C. Orth - Net Worth and Insider Trading
Andrew C. Orth Net Worth
The estimated net worth of Andrew C. Orth is at least $18,728 dollars as of 2024-11-13. Andrew C. Orth is the Chief Commercial Officer of Krystal Biotech Inc and owns about 100 shares of Krystal Biotech Inc (KRYS) stock worth over $18,728. Details can be seen in Andrew C. Orth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew C. Orth has not made any transactions after 2023-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew C. Orth
Andrew C. Orth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew C. Orth owns 1 companies in total, including Krystal Biotech Inc (KRYS) .
Click here to see the complete history of Andrew C. Orth’s form 4 insider trades.
Insider Ownership Summary of Andrew C. Orth
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KRYS | Krystal Biotech Inc | 2023-06-09 | Chief Commercial Officer |
Andrew C. Orth Latest Holdings Summary
Andrew C. Orth currently owns a total of 1 stock. Andrew C. Orth owns 100 shares of Krystal Biotech Inc (KRYS) as of June 9, 2023, with a value of $18,728.
Latest Holdings of Andrew C. Orth
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KRYS | Krystal Biotech Inc | 2023-06-09 | 100 | 187.28 | 18,728 |
Holding Weightings of Andrew C. Orth
Andrew C. Orth Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew C. Orth has made a total of 1 transactions in Krystal Biotech Inc (KRYS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Krystal Biotech Inc is the sale of 12,500 shares on June 9, 2023, which brought Andrew C. Orth around $2 Million.
Insider Trading History of Andrew C. Orth
- 1
Andrew C. Orth Trading Performance
Andrew C. Orth Ownership Network
Ownership Network List of Andrew C. Orth
Ownership Network Relation of Andrew C. Orth
Andrew C. Orth Owned Company Details
What does Krystal Biotech Inc do?
Who are the key executives at Krystal Biotech Inc?
Andrew C. Orth is the Chief Commercial Officer of Krystal Biotech Inc. Other key executives at Krystal Biotech Inc include director & 10 percent owner & President and CEO Krish S Krishnan , director & 10 percent owner & Chief Operating Officer Suma Krishnan , and Chief Accounting Officer Kathryn Romano .
Krystal Biotech Inc (KRYS) Insider Trades Summary
Over the past 18 months, Andrew C. Orth made 1 insider transaction in Krystal Biotech Inc (KRYS) with a net sale of 12,500. Other recent insider transactions involving Krystal Biotech Inc (KRYS) include a net sale of 300,000 shares made by Krish S Krishnan , a net sale of 300,000 shares made by Suma Krishnan , and a net sale of 76,515 shares made by Kathryn Romano .
In summary, during the past 3 months, insiders sold 100,000 shares of Krystal Biotech Inc (KRYS) in total and bought 0 shares, with a net sale of 100,000 shares. During the past 18 months, 809,015 shares of Krystal Biotech Inc (KRYS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 809,015 shares.
Krystal Biotech Inc (KRYS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Krystal Biotech Inc Insider Transactions
Andrew C. Orth Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew C. Orth. You might contact Andrew C. Orth via mailing address: 2100 Wharton Street, Suite 701, Pittsburgh Pa 15203.